HTR5A and Alzheimer disease: Moreover, the study highlighted the beneficial effect of blocking the 5-HT3 receptor by using palonosetron and, to a lesser extent, the α7nAChR by using MLA to attenuate AD-associated alterations via interfering with the interconnection between activated microglia/inflammasome/Aβ and the depleted ACh and 5-HT.